Dermatology Compounding

Compounding Alternatives & Advantages For Dermatology

A compounding pharmacy can make medications that have been discontinued, experiencing drug shortages, or not available in the United States. Dermatologists and other prescribers use a compounding pharmacy to obtain products that are more potent and effective than what they can get from drug manufacturers.

i.e. Hydroquinone is only available in formulations of 4-6%. A compounding pharmacy can make a formulation with 6%, 8%, or 10% hydroquinone. Other ingredients can be added to this formulation for relief in irritation.

There are many combinations of ingredients that can be made by a compounding pharmacy that are not commercially available as well as options that are non-comedogenic, hypoallergenic, oil-free, paraben-free and petrolatum-free.

Skin Disorders

Disorders of the skin can be a problem among patients of all ages. Common problems include: scarring, acne, rosacea, skin discoloration, psoriasis, and eczema. Numerous medications exist to help these conditions, but can often be costly and not covered by insurance. Pharmacists will work with your medical provider to provide a customized dermatological compounded formula for treating your condition at an affordable cost.

Compounding Can Be an Essential Resource

A Compounding pharmacy can be an essential resource for a patient who is suffering from a severe skin condition. This is especially helpful regarding patients that do not respond to other treatments.

Compounding can be utilized to treat a variety of dermatological conditions often by using a combination of drug products and strengths

Acne
Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial.
Click here to access the PubMed abstract of this article.

Anti-Aging & Cosmetics
Dermatol Surg 1999 Jun;25(6):450-4 The use of chemical peelings in the treatment of different cutaneous hyperpigmentations.
Click here to access the PubMed abstract of this article.

Melasma
J Res Med Sci. 2014 Aug;19(8):753-7. Topical tranexamic acid as a promising treatment for melasma.
Click here to access the PubMed abstract of this article.

Molluscum Contagiosum
Am Acad Dermatol. 2000;43:503-507 Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients.
Click here to access the PubMed abstract.

Numbing Cream
Need article here

Psoriasis
Am J Clin Dermatol. 2009;10(6):397-406. Topical clobetasol propionate in the treatment of psoriasis: a review of newer formulations.
Click here to access the PubMed abstract of this article.

Rosacea
Clin Exp Dermatol 2003 Jan;28(1):61-3 Topical application of NADH for the treatment of rosacea and contact dermatitis.
Click here to access the PubMed abstract of this article.

Scarring
Dermatol Ther (Heidelb). 2014 Dec;4(2):259-69. Case series: the effectiveness of Fatty acids from pracaxi oil in a topical silicone base for scar and wound therapy.
Click here to access the PubMed abstract of this article.

Sun Damage
J Drugs Dermatol 2002 Sep;1(2):127-31 Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight–a new study for the treatment of vitiligo.
Click here to access the PubMed abstract.

Vitiligo
J Drugs Dermatol 2002 Sep;1(2):127-31 Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight–a new study for the treatment of vitiligo.
Click here to access the PubMed abstract.

Warts
J Drugs Dermatol. 2006 May;5(5):418-24. Topical 5% 5-fluorouracil cream in the treatment of plantar warts: a prospective, randomized, and controlled clinical study.
Click here to access the PubMed abstract of this article.

Order a Refill

Prescribers

Contact Us